Bandrone Tablets 150 Mg

Approx. Rs 850 / TabletGet Latest Price

Product Details:

Bonviva (Ibandronic Acid) 150 mg Film-Coated Tablets
Manufactured by Roche (or licensed partners)

General Information

*Generic Name: Ibandronic Acid / Ibandronate Sodium
*Brand Name Bonviva (also sold under names like Bondronat in injection form)
Strength: 150 mg
Form: Film-coated tablet
Color: White to off-white, oblong
Imprint May vary depending on country and manufacturer batch

---

Indications

Bonviva is primarily used for the treatment and prevention of:

Osteoporosis in postmenopausal women
*Reduction of vertebral fractures risk

---

Pharmacological Class

ClassBisphosphonate
Mechanism of Action Inhibits osteoclast-mediated bone resorption, thereby strengthening bone mass

---

Dosage and Administration

Dose 150 mg once a month
Route Oral
Instructions

   Take on an empty stomach, with a full glass of plain water
  Do not lie down, eat, or drink anything else for at least 60 minutes after taking
Take the tablet on the same day each month

---

Contraindications

Hypocalcemia (low calcium levels)
Esophageal abnormalities
Inability to sit or stand upright for at least 60 minutes
Known hypersensitivity to ibandronate or any tablet ingredient

Side Effects

Common:

Gastrointestinal irritation (heartburn, nausea)
Musculoskeletal pain (joint, bone, or muscle pain)
Flu-like symptoms after first dose

Rare but serious:

Esophagitis
Osteonecrosis of the jaw (ONJ)